Blauvelt,  01/08/2020

Visit Schreiner MediPharm at Pharmapack in Paris, Feb. 5-6 at Hall 7.2, Booth D46

At Pharmapack, Schreiner MediPharm to Showcase New Robust RFID Pharma-Label and Supply Chain Security Solutions

The new Robust RFID-Label from Schreiner MediPharm ensures reliable end-to-end functionality of the RFID chip.

Schreiner MediPharm, a specialist in innovative functional labels for the pharmaceutical industry, will showcase its new Robust RFID-Label, which offers reliable end-to-end functionality from production to final use. At Hall 7.2, Booth D46, the company also will showcase two products for pharma container integrity: Cap-Lock for sealing prefilled syringes; and Flexi-Cap Prime, which irreversibly indicates any tampering attempt on a vial.


Robust RFID-Label Ensures Reliable Connectivity
Interaction between users and pharmaceutical manufacturers, as well as communication between products and medical devices, are important connectivity-centric aspects for pharmaceutical applications. Equipping pharmaceutical products and medical devices with RFID labels results in smart devices that help optimize processes and enhance ease and safety of use. Extreme robustness and perfect performance of the RFID labels throughout the various processing stages and across the entire supply chain are prerequisites for achieving these objectives. Particularly critical to ensuring robustness is the label’s design.

Schreiner MediPharm’s new Robust RFID-Label consists of a label-integrated RFID tag secured via the label’s special construction. This avoids potential damage to the RFID chip due, for example, to mechanical impact during the manufacturing and handling processes. End-to-end performance of the RFID chip is therefore assured from production to final use – especially on round containers with narrow radii. Schreiner MediPharm customizes the label’s design to suit individual applications and pharmaceutical manufacturing setups. All totaled, pharmaceutical manufacturers are provided with an effective and reliable solution supporting product and patient safety. 

Cap-Lock and Flexi-Cap Prime Support Integrity of the Supply Chain
Ever since the EU Falsified Medicines Directive came into effect, tampering with secondary packaging of prescription medicines has been more difficult. However, legislation has not yet resolved the issue of ensuring the integrity of primary containers. With Cap-Lock and Flexi-Cap Prime, Schreiner MediPharm is presenting two security concepts that prevent undetected opening of a primary container, thereby ensuring its integrity: The Cap-Lock cap adapter seals prefilled luer-lock syringes and reliably indicates if a syringe has been previously opened. While the Flexi-Cap Prime cap label makes any attempt at tampering with a vial irreversibly visible. 

Schreiner MediPharm will also take part in the Pharmapack conference program and present the following topics together with its partners:
•    A Novel Container Integrity Concept for Vials – Use Cases and Concepts for Machine Processability
Workshop session with Bausch + Ströbel Maschinenfabrik Ilshofen, February 5, 10.00 – 10.40 a.m.
•    Pharmaceutical Labeling for Prefilled Syringes – Providing More than just Information 
Learning lab with Schott AG, February 6, 3.10 – 3.40 p.m.


For further information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group LP
300 Corporate Drive, Suite 10
Blauvelt, NY 10913
Phone (845) 848-9000
Fax  (845) 848-9041
info@schreiner-medipharm.com 
www.schreiner-medipharm.com